Freund Michael R, Kent Ilan, Horesh Nir, Smith Timothy, Wexner Steven D
Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, Florida, USA.
Colorectal Dis. 2022 Apr;24(4):484-490. doi: 10.1111/codi.16035. Epub 2022 Jan 10.
Surgical resection for Crohn's disease (CD) remains noncurative, therefore recurrence is a significant problem. Although numerous factors affecting surgical outcomes in redo ileocolic resection have been previously described, no study has considered the relation between the interval of time from initial ileocolic resection to the redo procedure and its effect on surgical outcomes. The aim of this study was to explore this relationship.
A retrospective review of all adult patients undergoing redo ileocolic resection for CD between 2011 to 2020 was conducted. Patients were divided into two groups based on time from initial ileocolic resection. Patients operated within 10 years of their initial surgery (≤10 years) were assigned to the early group, while patients operated >10 years after initial surgery were allocated to the late group. Primary outcome was the 30-day postoperative major complication rate.
Fifty-eight patients underwent redo ileocolic resection, 24 in the early group and 34 in the late group. Apart from older median age in the late group (56 vs. 46.5 years, p = 0.026), the groups were similar for patient factors, disease site and behaviour, use of immune-suppressing medication and procedural factors. Significant differences in 30-day postoperative morbidity included longer length of stay (6 vs. 5 days, p = 0.035), a higher major complication rate (23.5% vs. 4.1%, p = 0.04) and higher readmission rate (26.4% vs. 4.1%, p = 0.035) in the late group. The overall complication rate remained nonsignificant (37.5% vs. 61.8%, p = 0.1).
Redo ileocolic resection, when performed >10 years from the initial ileocolic resection, may be associated with increased morbidity, specifically higher rates of major postoperative complications, a longer length of stay and more readmissions.
克罗恩病(CD)的手术切除仍无法治愈,因此复发是一个重大问题。尽管先前已描述了许多影响再次回结肠切除术手术结果的因素,但尚无研究考虑从初次回结肠切除术到再次手术的时间间隔与其对手术结果的影响之间的关系。本研究的目的是探讨这种关系。
对2011年至2020年间所有接受CD再次回结肠切除术的成年患者进行回顾性研究。根据初次回结肠切除术后的时间将患者分为两组。初次手术后10年内接受手术(≤10年)的患者被分配到早期组,而初次手术后超过10年接受手术的患者被分配到晚期组。主要结局是术后30天的主要并发症发生率。
58例患者接受了再次回结肠切除术,早期组24例,晚期组34例。除晚期组的年龄中位数较大(56岁对46.5岁,p = 0.026)外,两组在患者因素、疾病部位和行为、免疫抑制药物的使用和手术因素方面相似。术后30天发病率的显著差异包括晚期组住院时间更长(6天对5天,p = 0.035)、主要并发症发生率更高(23.5%对4.1%,p = 0.04)和再入院率更高(26.4%对4.1%,p = 0.035)。总体并发症发生率仍无显著差异(37.5%对61.8%,p = 0.1)。
初次回结肠切除术后10年以上进行再次回结肠切除术可能与发病率增加有关,特别是术后主要并发症发生率更高、住院时间更长和再入院次数更多。